<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Introduction: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is the leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> from gastrointestinal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in the US </plain></SENT>
<SENT sid="1" pm="."><plain>Chemokines and their receptors are being recognized as key regulators of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and increasingly as therapeutic targets for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancers</z:e>, including <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Several studies have demonstrated that IL-8 and its receptor CXCR2 are two of the most significantly upregulated chemokines in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>IL-8 through binding to its receptors can act not only on <z:mp ids='MP_0001845'>inflammatory responses</z:mp> and <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e>, but also on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells via their receptors to promote migration, invasion and proliferation, and in vivo <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Therefore, IL-8 and CXCR2 may be important therapeutic targets against <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Areas covered: This review provides an update on the roles of IL-8 and its receptors in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> preclinical models and translational relevance: i) Increased expression of IL-8 and/or its receptors has been characterized in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells; ii) IL-8 signaling pathway in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells; iii) targeting IL-8 expression, or receptor-targeted strategies in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, eliminates the redundant function of IL-8 signaling and determines the effects of suppressing IL-8 signaling on <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and development </plain></SENT>
<SENT sid="6" pm="."><plain>Expert opinion: IL-8 and its receptor CXCR2 may function as significant regulatory factors within the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment and be important therapeutic targets in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Not only may they lead to antitumor properties, but also they may chemosensitize the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> toward the current chemotherapy </plain></SENT>
</text></document>